Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Change in Acquisitions & Divestments: 2021-2024

Historic Change in Acquisitions & Divestments for IDEAYA Biosciences (IDYA) over the last 4 years, with Dec 2024 value amounting to $692.6 million.

  • IDEAYA Biosciences' Change in Acquisitions & Divestments fell 6.87% to $180.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $682.3 million, marking a year-over-year increase of 3.06%. This contributed to the annual value of $692.6 million for FY2024, which is 57.45% up from last year.
  • According to the latest figures from FY2024, IDEAYA Biosciences' Change in Acquisitions & Divestments is $692.6 million, which was up 57.45% from $439.9 million recorded in FY2023.
  • IDEAYA Biosciences' 5-year Change in Acquisitions & Divestments high stood at $692.6 million for FY2024, and its period low was $225.8 million during FY2022.
  • Over the past 3 years, IDEAYA Biosciences' median Change in Acquisitions & Divestments value was $439.9 million (recorded in 2023), while the average stood at $452.8 million.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first declined by 7.42% in 2022, then soared by 94.77% in 2023.
  • Over the past 4 years, IDEAYA Biosciences' Change in Acquisitions & Divestments (Yearly) stood at $244.0 million in 2021, then fell by 7.42% to $225.8 million in 2022, then spiked by 94.77% to $439.9 million in 2023, then skyrocketed by 57.45% to $692.6 million in 2024.